Emma Lardner
Impact in
- Ophthalmology top 5%
- Glaucoma and retinal disorders
- Retinal Diseases and Treatments
- Ocular Oncology and Treatments
-
- Neuroinflammation and Neurodegeneration Mechanisms
- Neurological Disorders and Treatments
Papers in
-
- Retinal Diseases and Treatments 10
- Glaucoma and retinal disorders 8
- Ocular Oncology and Treatments 6
-
- Retinal Development and Disorders 8
- Co-authors
- Pete A. Williams (8 shared papers)James R. Tribble (7 shared papers)Gustav Stålhammar (11 shared papers)Helder André (8 shared papers)Anders Kvanta (7 shared papers)James P. Morgan (2 shared papers)G.‐B. van Setten (1 shared paper)Monica Aronsson (3 shared papers)
In The Last Decade
Emma Lardner
18 papers receiving 272 citations
Peers
Comparison fields: 5 of 49
- Ophthalmology 147
- Neurology 57
- Molecular Biology 137
- Radiology, Nuclear Medicine and Imaging 41
- Geriatrics and Gerontology 6
Countries citing papers authored by Emma Lardner
This map shows the geographic impact of Emma Lardner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Lardner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Lardner more than expected).
Fields of papers citing papers by Emma Lardner
This network shows the impact of papers produced by Emma Lardner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Lardner. The network helps show where Emma Lardner may publish in the future.
Co-authors
The 25 scholars most cited alongside Emma Lardner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 47 | |
| 2 | 2021 | 34 | |
| 3 | 2020 | 27 | |
| 4 | 2022 | 25 | |
| 5 | 2021 | 24 | |
| 6 | 2023 | 19 | |
| 7 | 2020 | 14 | |
| 8 | 2017 | 13 | |
| 9 | 2020 | 12 | |
| 10 | 2018 | 12 | |
| 11 | 2023 | 11 | |
| 12 | 2023 | 8 | |
| 13 | 2021 | 8 | |
| 14 | 2021 | 7 | |
| 15 | 2023 | 4 | |
| 16 | 2021 | 3 | |
| 17 | 2025 | 2 | |
| 18 | 2023 | 2 | |
| 19 | 2025 | 0 | |
| 20 | 2024 | 0 |
About Emma Lardner
Emma Lardner is a scholar working on Ophthalmology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Neurology and Oncology, having authored 20 papers that have together received 272 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (10 papers), Glaucoma and retinal disorders (8 papers), Retinal Development and Disorders (8 papers), Ocular Oncology and Treatments (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Cutaneous Melanoma Detection and Management (2 papers), Retinopathy of Prematurity Studies (2 papers) and Retinal Imaging and Analysis (2 papers). The work is most often cited by research in Ophthalmology (147 citations), Neurology (57 citations), Molecular Biology (137 citations), Radiology, Nuclear Medicine and Imaging (41 citations) and Geriatrics and Gerontology (6 citations). Emma Lardner has collaborated with scholars based in Sweden, Italy and Australia. Frequent co-authors include Pete A. Williams, James R. Tribble, Gustav Stålhammar, Helder André, Anders Kvanta, James P. Morgan, G.‐B. van Setten, Monica Aronsson, Pankaj Kumar and Fredrik Lanner. Their work appears in journals such as Acta Neuropathologica Communications, Translational Vision Science & Technology, Acta Ophthalmologica, Nature Communications and Cell Reports Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.